Patent · US Active

Zika virus purification

US11331382B2 · kind B2 · utility

4Cited by

6References

9Claims

0Family size

Assignee

Valneva Austria GmbH · AT

Inventors

Jana Barbero Calzado · Wien, AT
Mario Nebenführ · Wien, AT
Robert Schlegl · Siegenfeld, AT
Michael Weber · Wien, AT
Jürgen Heindl-Wruss · Wien, AT

Key dates

Filing date	Dec 23, 2016
Grant date	May 17, 2022
Priority date	—
Expiry date	Dec 23, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are improved purification methods for Zika virus vaccines and compositions. Also described are Zika vaccines and methods of producing and administering said Zika vaccines to subjects in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.